# OnCo record hpv-positive-oropharyngeal-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "hpv-positive-oropharyngeal-cancer" ;
  schema:name "HPV-positive oropharyngeal cancer"@en ;
  schema:alternateName "p16-positive oropharyngeal cancer"@en, "HPV-associated oropharyngeal squamous cell carcinoma"@en, "HPV-driven throat cancer"@en ;
  schema:description "Throat cancers caused by HPV are usually cured with chemoradiation or robotic surgery, so trials now ask how much treatment can be taken away: swapping cisplatin for cetuximab failed, cutting the radiation dose has worked only after surgery so far, and blood tests for HPV DNA may pick out the patients who can safely have less."@en ;
  schema:url <https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/HPV-positive_oropharyngeal_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/HPV-positive_oropharyngeal_cancer> ;
  onco:tag "subtype-page", "head-and-neck" ;
  onco:keyPapers <https://onco.cc/key-papers/paper-ang-hpv-oropharyngeal-nejm-2010/>, <https://onco.cc/key-papers/paper-rtog-1016-lancet-2019/>, <https://onco.cc/key-papers/paper-de-escalate-lancet-2019/>, <https://onco.cc/key-papers/paper-e3311-transoral-surgery-ferris-jco-2022/> ;
  onco:pipeline <https://onco.cc/technologies/cthpv-dna/>, <https://onco.cc/trials/pathos/>, <https://onco.cc/trials/nrg-hn002-hn005/>, <https://onco.cc/ideas/idea-cthpv-adapted-deescalation/>, <https://onco.cc/drugs/bnt113/>, <https://onco.cc/trials/nct04534205/>, <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:standardOfCare <https://onco.cc/terms/hpv-p16/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/tors/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/trials/ecog-e3311/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/trials/rtog-1016/>, <https://onco.cc/trials/de-escalate/>, <https://onco.cc/trials/nrg-hn002-hn005/>, <https://onco.cc/trials/pathos/>, <https://onco.cc/technologies/cthpv-dna/>, <https://onco.cc/pairings/hpv-deescalation-caution/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/cthpv-dna/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/keynote-048/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/>, <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/ideas/idea-prev-hpv-male-catchup-oropharynx/> .